Provided by Tiger Trade Technology Pte. Ltd.

SELLAS Life Sciences Group Inc.

13.34
+0.13000.98%
Post-market: 13.33-0.0100-0.07%19:59 EDT
Volume:7.45M
Turnover:98.70M
Market Cap:2.69B
PE:-62.83
High:13.67
Open:13.33
Low:12.94
Close:13.21
52wk High:15.88
52wk Low:1.39
Shares:201.95M
Float Shares:199.00M
Volume Ratio:0.85
T/O Rate:3.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2123
EPS(LYR):-0.2463
ROE:-39.63%
ROA:-23.30%
PB:19.57
PE(LYR):-54.15

Loading ...

Canaccord Genuity Sticks to Their Buy Rating for Solstice Minerals Limited (SLS)

TIPRANKS
·
2 hours ago

Social Buzz: Wallstreetbets Stocks Mixed Premarket Monday; SELLAS Life Sciences to Advance, Tesla to Decline

MT Newswires Live
·
Yesterday

Is SELLAS Life Sciences Group (SLS) Overvalued As Trial Milestones And Takeover Changes Stir Questions?

Simply Wall St.
·
Yesterday

Is Uncertain Galinpepimut-S Data Timing Reshaping SELLAS Life Sciences Group’s (SLS) Strategic Story?

Simply Wall St.
·
Aug 29

SELLAS Life Sciences Stock (SLS) Has a Major Catalyst on the Horizon

TIPRANKS
·
Aug 24

Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Monday; Sellas to Rise, Applied Optoelectronics to Fall

MT Newswires Live
·
Aug 24

Are SELLAS Life Sciences (SLS) Loss Trends Masking a Shifting Cancer Vaccine Investment Narrative?

Simply Wall St.
·
Aug 22

Analysts Offer Insights on Healthcare Companies: Decibel Cannabis Company (OtherDBCCF) and SELLAS Life Sciences Group (SLS)

TIPRANKS
·
Aug 21

Moderna data bode well for Sellas into imminent readout, says Maxim

TIPRANKS
·
Aug 19

Sims (ASX:SGM) Shares Reprice After Profit Rebound Meets SLS Volatility

Simply Wall St.
·
Aug 18

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 14

Sellas Life Sciences Q2 Loss Narrows

MT Newswires Live
·
Aug 12

Earnings Flash (SLS) SELLAS Life Sciences Posts Q2 Loss $0.05, vs. FactSet Est of $0.05 Loss

MT Newswires Live
·
Aug 12

SELLAS Life Sciences Gr Q2 EPS $(0.05) Misses $(0.04) Estimate

Benzinga Earnings
·
Aug 12

Sellas Life Sciences Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 12

Sellas Life Sciences Q2 Basic EPS USD -0.05

THOMSON REUTERS
·
Aug 12

Sellas Life Sciences Q2 Net Income USD -9.605 Million

THOMSON REUTERS
·
Aug 12

Press Release: Sellas Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Aug 12

Sellas Net Loss Widens 45,51% to $ 9,61 Juta in Q2 FY26

Reuters
·
Aug 12

Canaccord Genuity Keeps Their Buy Rating on Solstice Minerals Limited (SLS)

TIPRANKS
·
Aug 04